Types of Solid Organ Allograft Rejection

 Hyperacute Rejection 

In hyperacute rejection, thrombosis of the vasculature occurs immediately after anasto-mosis of the solid organ graft blood vessels and release of the surgical clamp, which is caused by the presence of preformed anti-bodies that bind to the endothelial anti-gens. In the early days of transplantation, ABO incompatibility was the main culprit. Because ABO incompatibility is largely avoided now, hyperacute rejection usually occurs when IgG antibodies react with for-eign M HC antigens or lesser-known alloan-tigens in the endothelium. The latter may be associated with accelerated hyperacute rejec-tion that lasts a few days. Adequate screen-ing for preformed anti-HLA antibodies and ABO testing should prevent hyperacute rejection.

 

Acute Rejection

 

Acute rejection is an inflammatory process affecting the vasculature and parenchyma of the allograft, which occurs a few days to a week after transplantation. Activated T cells can cause direct lysis of the graft or release cytokines that promote inflammation in the allograft. The endothelial cells appear to be the earliest targets for rejection with re-sultant endotheliitis. A humoral-mediated response causes binding of antibodies to the blood vessel wall with resultant necro-sis and occlusion of the arteries.

 

Chronic Rejection

 

Fibrosis with intimal thickening and eventual occlusion of medium-sized arteries that supply the graft characterizes chronic rejection. The fibrosis seen in chronic rejection is presumed to be a by-product of previous inflammation from acute rejection or from cytokines that stimulated fibroblast produc-tion. Chronic allograft rejection accounts for the majority of allograft failures.


Comments

Popular posts from this blog

Hematopoietic Stem Cell Transplantation

Basic Components of the Immune System

Etiologic Considerations of Rheumatic Fever